[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370304-105":59,"doc-detail-370304-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","circulating-rna-markers-associated-with-adenomacarcinoma-sequence-in-colorectal-cancer","Circulating RNA Markers Associated with Adenoma–Carcinoma Sequence in Colorectal Cancer","","Colorectal cancer advances through a defined adenoma–carcinoma sequence (ACS), which underpins early detection but is constrained by tissue-sampling requirements that hinder accurate staging. Liquid biopsies offer non-invasive monitoring, yet circulating tumor DNA and extracellular RNA often reflect genetic alterations or passive RNA release rather than active tumor–immune processes. This study identifies circulating RNA biomarkers tied to ACS progression by analyzing blood RNA from 160 participants across five clinical groups. RNA sequencing with gene ontology and protein–protein interaction analyses revealed stage-specific transcripts, including IFI27, DEFA4, MPO, and CD177, supporting their potential for early, non-invasive screening and diagnosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/circulating-rna-markers-associated-with-adenomacarcinoma-sequence-in-colorectal-cancer/370304/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/circulating-rna-markers-associated-with-adenomacarcinoma-sequence-in-colorectal-cancer/370304.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are tissue-based methods insufficient for colorectal cancer staging?","Question",{"text":112,"@type":113},"Tissue sampling limits accurate staging and reduces the practicality of ACS-based surveillance, motivating the search for non-invasive biomarkers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What was the goal of this study?",{"text":117,"@type":113},"To identify circulating RNA biomarkers associated with the adenoma–carcinoma sequence by analyzing blood samples from multiple colorectal-related groups.",{"name":119,"@type":110,"acceptedAnswer":120},"Which circulating RNA transcripts were linked to specific clinical groups?",{"text":121,"@type":113},"IFI27 was associated with the symptomatic non-disease control group, DEFA4 with the non-advanced adenoma group, MPO with the advanced adenoma group, and CD177 with colorectal cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370304,1790724927,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article  \nCirculating RNA Markers Associated with Adenoma–Carcinoma Sequence in Colorectal Cancer  \nLi Ah Kim 1, Jin Han 1, Tae Il Kim 2, Jae Jun Park 2, Jae Myun Lee 3, Jong Koo Kim 4, Sunyoung Park 5 and Hyeyoung Lee 1,6, *  \nAcademic Editor: Carmine Stolfi  \nReceived: 13 December 2024  \nRevised: 2 February 2025  \nAccepted: 4 February 2025  \nPublished: 11 February 2025  \nCitation: Kim, L.A.; Han, J.; Kim, T.I.; Park, J.J.; Lee, J.M.; Kim, J.K.; Park, S.; Lee, H. Circulating RNA Markers Associated with Adenoma–Carcinoma Sequence in Colorectal Cancer. Int. J. Mol. Sci. 2025, 26, 1518. [https://](https://)[ ](https://)[doi.org/10.3390/ijms26041518](doi.org/10.3390/ijms26041518)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Biomedical Laboratory Science, College of Software and Digital Healthcare Convergence, Yonsei University Mirae Campus, Wonju 26493, Republic of Korea; [riah0416@naver.com](riah0416@naver.com) (L.A.K.); [kristenlovemom@gmail.com](kristenlovemom@gmail.com) (J.H.)  \n2 Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; [taeilkim@yuhs.ac](taeilkim@yuhs.ac) (T.I.K.); [jaejpark@yuhs.ac](jaejpark@yuhs.ac) (J.J.P.)  \n3 Department of Microbiology and Immunology, Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; [jaemyun@yuhs.ac](jaemyun@yuhs.ac)  \n4 Department of Family Medicine, Wonju College of Medicine, Yonsei University, Wonju 26426, Republic of Korea; [kimjk214@yonsei.ac.kr](kimjk214@yonsei.ac.kr)  \n5 School of Mechanical Engineering, Yonsei University, Seoul 03722, Republic of Korea; [angelsy88@gmail.com](angelsy88@gmail.com)  \n[6](6 INOGENIX Inc)[ INOGENIX Inc](6 INOGENIX Inc)., [Chuncheon 24232](Chuncheon 24232), [Republic of Korea](Republic of Korea)  \n* [Correspondence: hyelee@yonsei.ac.kr](Correspondence: hyelee@yonsei.ac.kr); Tel.: +82-70-8808-8345  \nAbstract: Colorectal cancer progresses through a well-defined adenoma–carcinoma sequence (ACS), which is pivotal for early detection and intervention. While ACS-based surveillance has been instrumental, its reliance on tissue sampling limits accurate staging. Liquid biopsies, including circulating tumor DNA (ctDNA) and extracellular RNA, have emerged as non-invasive alternatives, yet they primarily detect genetic alterations or passive RNA release rather than active biological processes. Thus, there is a need for biomarkers that reflect real-time immune responses and tumor–microenvironment interactions during ACS progression. This study aimed to identify circulating RNA biomarkers associated with ACS by analyzing blood samples from 160 individuals across five groups: colorectal cancer, advanced adenoma, non-advanced adenoma, symptomatic non-disease control, and healthy control. RNA sequencing coupled with gene ontology and protein– protein interaction analyses identified stage-specific circulating transcripts. Notably, IFI27 was linked to the symptomatic non-disease control group, DEFA4 to the non-advanced adenoma group, MPO to the advanced adenoma group, and CD177 to the colorectal cancer group. These findings suggest that colorectal-cancer-related circulating RNA markers reflect host immune responses during ACS progression, supporting their potential role in early detection and non-invasive diagnoses. By addressing critical gaps in early colorectal cancer detection, this study advances the utility of circulating RNA biomarkers and liquid biopsies in colorectal cancer screening and clinical management.  \nKeywords: adenoma–carcinoma sequence; colorectal cancer; differentially expressed ge","cbCaioOHNWVYJ9zf","https://ap.wps.com/l/cbCaioOHNWVYJ9zf","pdf",4891861,14,"English","# Introduction\n## Background and clinical challenge\n## Liquid biopsy rationale and limitations\n# Study aim and approach\n## Participant groups and sampling\n## RNA sequencing and bioinformatics analyses\n# Results\n## Stage-specific circulating transcripts\n# Discussion\n## Immune responses during ACS progression\n# Conclusion\n## Implications for early detection and clinical management","[{\"question\":\"Why are tissue-based methods insufficient for colorectal cancer staging?\",\"answer\":\"Tissue sampling limits accurate staging and reduces the practicality of ACS-based surveillance, motivating the search for non-invasive biomarkers.\"},{\"question\":\"What was the goal of this study?\",\"answer\":\"To identify circulating RNA biomarkers associated with the adenoma–carcinoma sequence by analyzing blood samples from multiple colorectal-related groups.\"},{\"question\":\"Which circulating RNA transcripts were linked to specific clinical groups?\",\"answer\":\"IFI27 was associated with the symptomatic non-disease control group, DEFA4 with the non-advanced adenoma group, MPO with the advanced adenoma group, and CD177 with colorectal cancer.\"}]","Circulating RNA Markers Associated with Adenoma–Carcinoma Sequence in Colorectal Cancer | PDF",1790187886,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a760ab1e7f93c8a33a5a76ebbefcfde3.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0918c6e90a448ea5b133796db710a70.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da584fcdc91d1e787280fb61e7e477dd.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd78861e7dfe85d15af27625e5512486.webp",980,1385]